HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Jeffrey H Omens Selected Research

cysteine and glycine-rich protein 3

4/2007High-resolution longitudinal MRI of the transition to heart failure.
8/2005Young MLP deficient mice show diastolic dysfunction before the onset of dilated cardiomyopathy.
2/2002Muscle LIM protein deficiency leads to alterations in passive ventricular mechanics.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Jeffrey H Omens Research Topics

Disease

7Hypertrophy
01/2018 - 03/2003
7Heart Failure
11/2017 - 02/2002
6Myocardial Infarction
03/2016 - 06/2005
5Heart Diseases (Heart Disease)
01/2019 - 04/2007
4Dilated Cardiomyopathy (Cardiomyopathy, Congestive)
04/2013 - 02/2002
3Infarction (Infarctions)
03/2016 - 06/2005
3Ventricular Remodeling
03/2016 - 06/2005
3Cardiomegaly (Heart Hypertrophy)
03/2016 - 04/2003
3Cicatrix (Scar)
04/2009 - 06/2005
2Fibrosis (Cirrhosis)
03/2016 - 06/2005
2Cardiomyopathies (Cardiomyopathy)
08/2012 - 07/2005
2Hypoxia (Hypoxemia)
03/2008 - 07/2005
1Tetralogy of Fallot (Fallot Tetralogy)
05/2021
1Cardiac Arrhythmias (Arrythmia)
12/2014
1Arrhythmogenic Right Ventricular Dysplasia (Arrhythmogenic Right Ventricular Cardiomyopathy)
03/2014
1Bundle-Branch Block (Fascicular Block)
04/2009
1Necrosis
03/2008
1Myocardial Ischemia (Ischemic Heart Diseases)
06/2007
1Reperfusion Injury
06/2007
1Ischemia
06/2005
1Ventricular Dysfunction
02/2002

Drug/Important Bio-Agent (IBA)

5Proteins (Proteins, Gene)FDA Link
04/2015 - 02/2002
4CollagenIBA
03/2008 - 04/2003
3cysteine and glycine-rich protein 3IBA
04/2007 - 02/2002
2CalciumIBA
01/2018 - 02/2014
2Transcription Factors (Transcription Factor)IBA
11/2017 - 03/2016
2EnzymesIBA
03/2016 - 03/2008
2ConnectinIBA
08/2012 - 12/2008
2Oxygen (Dioxygen)IBA
03/2008 - 07/2005
1Biomarkers (Surrogate Marker)IBA
05/2021
1sacubitrilIBA
11/2017
1Valsartan (Vals)FDA Link
11/2017
1Drug CombinationsIBA
11/2017
1Pharmaceutical PreparationsIBA
11/2017
1RNA (Ribonucleic Acid)IBA
03/2016
1HydrogelsIBA
03/2016
1Anti-Arrhythmia AgentsIBA
10/2015
1Calcium-Calmodulin-Dependent Protein Kinase Type 2IBA
12/2014
1ConnexinsIBA
03/2014
1VinculinIBA
04/2013
1Myosins (Myosin)IBA
04/2012
1ElementsIBA
04/2009
1Adenosine Triphosphate (ATP)IBA
03/2008
1BiglycanIBA
03/2008
1sphingosine 1-phosphate (sphingosine-1-phosphate)IBA
06/2007
1Sphingosine-1-Phosphate ReceptorsIBA
06/2007
1Intravenous Immunoglobulins (IVIG)FDA Link
07/2005
1Atrial Natriuretic Factor (ANF)IBA
07/2005
1ActininIBA
07/2005
1Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)IBA
07/2005
1CytokinesIBA
07/2005
1Etanercept (Enbrel)FDA Link
07/2005
1Matrix Metalloproteinases (MMPs)IBA
07/2005
1Ventricular MyosinsIBA
07/2005
1Small Leucine-Rich ProteoglycansIBA
06/2005
1DecorinIBA
06/2005
1Advanced Glycation End ProductsIBA
04/2003
1Elastomers (Elastomer)IBA
03/2003

Therapy/Procedure

3Therapeutics
01/2019 - 08/2014
2Injections
03/2016 - 01/2011
1Cardiac Resynchronization Therapy
04/2009
1Immunomodulation
07/2005